12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Wednesday's intraday session, several healthcare stocks experienced significant movements. Adial Pharmaceuticals led the gainers with a 61.6% increase, while Acorda Therapeutics headed the losers with a 20.4% decrease. Other notable movers included Jaguar Health, Orgenesis, BioSig Technologies, and Telomir Pharmaceuticals on the gainers' side, and Kineta, DocGo, Biophytis, Yield10 Bioscience, and Eyenovia among the losers.
April 10, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acorda Therapeutics stock decreased by 20.4% to $0.81, with a market cap of $1.0 million.
The sharp decline in Acorda Therapeutics' stock price suggests negative investor sentiment or adverse developments within the company or its market environment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Adial Pharmaceuticals shares surged 61.6% to $1.83, with a market cap of $7.4 million.
The significant surge in Adial Pharmaceuticals' stock price indicates strong investor interest, potentially due to positive company developments or market conditions favoring healthcare stocks.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
BioSig Technologies shares moved upwards by 15.43% to $1.87, with a market cap of $17.4 million.
BioSig Technologies' stock appreciation could indicate positive developments within the company or an uptick in investor interest in the healthcare sector.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Jaguar Health shares rose 32.22% to $0.12, with a market value of $32.8 million.
Jaguar Health's stock price increase could reflect positive market reception to company news or broader sector momentum.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Orgenesis stock rose 27.83% to $0.62, with a market value of $21.1 million.
The increase in Orgenesis' stock price may be driven by investor optimism towards the company's prospects or favorable industry trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Telomir Pharmaceuticals shares rose 12.84% to $7.73, with a market value of $228.8 million.
The rise in Telomir Pharmaceuticals' stock price suggests positive investor sentiment, possibly due to encouraging company news or sector trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90